Anna Sundlöv
1 – 10 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
Warfvinge, Carl Fredrik LU ; Gustafsson, Johan LU
; Roth, Daniel
LU
; Tennvall, Jan
LU
; Svensson, Johanna
; Bernhardt, Peter
; Åkesson, Anna
; Wieslander, Elinore
LU
; Sundlöv, Anna
LU
and Sjögreen Gleisner, Katarina
LU
(2024)
In Journal of Nuclear Medicine
65(7).
p.1070-1075
- Contribution to journal › Article
-
Mark
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms
Sorbye, H. ; Hjortland, G. O. ; Vestermark, L. W. ; Sundlov, A. LU
; Assmus, J.
; Couvelard, A.
; Perren, A.
and Langer, S. W.
(2024)
In Journal of Neuroendocrinology
36(11).
- Contribution to journal › Article
-
Mark
Optimal follow-up with somatostatin receptor PET/CT imaging in patients with small intestinal neuroendocrine tumours
Ohlsson, Håkan LU
; Spaak, Elisabeth
; Gålne, Anni
LU
; Sundlöv, Anna
LU
and Almquist, Martin
LU
(2024)
In Journal of Neuroendocrinology
36(8).
- Contribution to journal › Article
-
Mark
Retrospective evaluation of the predictive value of tumour burden at baseline [
68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT.
Gålne, Anni LU
; Sundlöv, Anna
LU
; Enqvist, Olof
LU
; Sjögreen Gleisner, Katarina
LU
; Larsson, Erik
and Trägårdh, Elin
LU
(2024)
In EJNMMI reports
8.
p.1-19
- Contribution to journal › Article
- 2023
-
Mark
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms
Dam, Gitte ; Grønbæk, Henning ; Sundlöv, Anna LU
; Botling, Johan
; Sundin, Anders
; Petersen, Rene Horsleben
; Welin, Staffan
; Evensen, Espen Thiis
; Sorbye, Halfdan
and Tabaksblat, Elizaveta
, et al.
(2023)
In Acta Oncologica
62(5).
p.431-437
- Contribution to journal › Scientific review
-
Mark
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
Venizelos, Andreas ; Sorbye, Halfdan ; Elvebakken, Hege ; Perren, Aurel ; Lothe, Inger Marie B. ; Couvelard, Anne ; Hjortland, Geir Olav ; Sundlöv, Anna LU
; Svensson, Johanna
and Garresori, Harrish
, et al.
(2023)
In Endocrine-Related Cancer
30(10).
- Contribution to journal › Article
-
Mark
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
Morken, Siren ; Langer, Seppo W. ; Sundlöv, Anna LU
; Vestermark, Lene Weber
; Ladekarl, Morten
; Hjortland, Geir Olav
; Svensson, Johanna B.
; Tabaksblat, Elizaveta Mitkina
; Haslerud, Torjan Magne
and Assmus, Jörg
, et al.
(2023)
In British Journal of Cancer
129(12).
p.1930-1939
- Contribution to journal › Article
-
Mark
AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT
Gålne, Anni LU
; Enqvist, Olof
LU
; Sundlöv, Anna
LU
; Valind, Kristian
LU
; Minarik, David
LU
and Trägårdh, Elin
LU
(2023)
In European journal of hybrid imaging
7(1).
- Contribution to journal › Article
- 2022
-
Mark
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
Venizelos, Andreas ; Elvebakken, Hege ; Perren, Aurel ; Nikolaienko, Oleksii ; Deng, Wei ; Lothe, Inger Marie B ; Couvelard, Anne ; Hjortland, Geir Olav ; Sundlöv, Anna LU
and Svensson, Johanna B
, et al.
(2022)
In Endocrine-Related Cancer
29(1).
p.1-14
- Contribution to journal › Article
-
Mark
Dosimetric quantities of neuroendocrine tumors over treatment cycles with 177Lu-DOTA-TATE
Roth, Daniel LU
; Gustafsson, Johan
LU
; Warfvinge, Carl Fredrik
LU
; Sundlöv, Anna
LU
; Åkesson, Anna
; Tennvall, Jan
LU
and Sjögreen Gleisner, Katarina
LU
(2022)
In Journal of Nuclear Medicine
63(3).
p.399-405
- Contribution to journal › Article